InsidersTradesSigma
Attendo AB (publ): directors' dealings · Finland · FIN-FSA
FI:attendo-ab-publ-89bfe6SE0007666110FI·FIN-FSAMcap 15.5Bn€Healthcare
Explore the full insider trade history of Attendo AB (publ), a publicly traded company based in Finland. Shares are listed on FI FI, under the supervision of FIN-FSA. Operating in the Healthcare sector, Attendo AB (publ) has published 6 reports. Market capitalisation: €15.5bn. The latest transaction was filed on 17 September 2025 — Purchase. Among the most active insiders: Martin Tivéus. All data is free.
6
Insider Decl.
0
Thresholds
€584,002
5 ops.
Buy Volume
€174,123
1 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
107.80 €
Analyst consensus
2 analystsStrong buy
125.00 €Target 125.00 €(+16%)125.00 €
Income statement
Revenue18.99 Bn€
Gross profit8.61 Bn€45% margin
Net income813.0 M€4.6% margin
Valuation
PER (trailing)18.3x
PER (forward)13.6x
P/Book2.9x
Balance sheet & cash
Market cap15.47 Bn€
Total debt16.44 Bn€
Free Cash Flow2.65 Bn€
Debt / Equity290%
Profitability & ownership
ROE16.4%
ROA4.7%
% insiders11.3%
% institutions48.1%
Last declaration on 17 September 2025
Declarations6 total
Executives●Purchase31FIN-FSA
€7,6621,234 shares@ €6.20890.0000% mcap100.0% of flow
Aktie
FI:A003S365-1·
Ideal exit: 14 Jun 2026 (T+270)
Executives●Purchase30FIN-FSA
€114,56919,400 shares@ €5.90560.0007% mcap38.4% of flow
Aktie
FI:A003S041-1·
Ideal exit: 1 Jun 2026 (T+270)
Executives●Purchase19FIN-FSA
€5,8401,000 shares@ €5.84030.0000% mcap100.0% of flow
Aktie
FI:A003S028-1·
Ideal exit: 1 Jun 2026 (T+270)
Executives●Purchase19FIN-FSA
€446,13777,760 shares@ €5.73740.0029% mcap100.0% of flow
Aktie
FI:A003R032-1·
Ideal exit: 21 Apr 2026 (T+270)
Executives●Purchase26FIN-FSA
€9,7941,791 shares@ €5.46860.0001% mcap3.3% of flow
Aktie
FI:A003P772-1·
Ideal exit: 28 Feb 2026 (T+270)
Executives●Sale32FIN-FSA
€174,123158,730 shares@ €1.0970.0011% mcap58.3% of flow
Teckningsoption
FI:A003O671-1·
6 of 6 declarations